Assessing the impact of oxytocin use on postpartum hemorrhage
March 1st 2024A recent study reveals that while oxytocin dosage correlates with a slight uptick in postpartum hemorrhage (PPH) risk, the use of oxytocin augmentation doesn't significantly increase PPH or blood loss when compared to patients with similar obstetric profiles.
Read More
Study: Antibiotic therapy reduces intraamniotic inflammation in second trimester idiopathic bleeding
March 1st 2024A recent study revealed the efficacy of antibiotic therapy in reducing intraamniotic inflammation among patients experiencing idiopathic bleeding in the second trimester of pregnancy, shedding light on potential management strategies for this condition.
Read More
Placental oxygenation's link to fetal brain volumes
February 29th 2024Discover how transverse relaxation time mapping, a sensitive magnetic resonance imaging-based technique, unveils the relationship between placental oxygenation and fetal brain development, shedding light on potential biomarkers for assessing fetal well-being.
Read More
Enhancing ePN platforms for gonorrhea and chlamydia
February 28th 2024Recent study reveals the need for customizable electronic partner notification platforms for gonorrhea and chlamydia, highlighting the need for tailored solutions to improve sexually transmitted infection partner services.
Read More
Unveiling metabolic markers of Candida albicans infection
February 27th 2024Discover how metabolomics sheds light on potential biomarkers for early detection and treatment of Candida albicans-induced vulvovaginal candidiasis, offering crucial insights into the pathogenesis of this prevalent inflammatory condition.
Read More
Comparing IV and IM oxytocin for postpartum hemorrhage
February 27th 2024A recent investigation finds comparable safety and effectiveness between intravenous and intramuscular oxytocin administration, suggesting intramuscular administration may be preferable for postpartum hemorrhage prevention.
Read More
Understanding patient perspectives on fetal malpresentation management
February 26th 2024A recent investigation sheds light on patient preferences and concerns regarding external cephalic version versus cesarean section for managing fetal malpresentation, revealing gaps in counseling and the desire for more information.
Read More
Demystifying bacterial vaginosis: Understanding, treatment, and breaking stigmas
February 26th 2024Misunderstandings surrounding bacterial vaginosis can delay treatment, but advancements such as XACIATO offer effective solutions, emphasizing the importance of open communication and continued research for comprehensive women's health care.
Read More
FDA approves enmetazobactam for treatment of cUTIs
February 23rd 2024Enmetazobactam (Exblifep; Orchid Pharma) gains FDA approval for treating complicated urinary tract infections in adults after demonstrating superiority over piperacillin-tazobactam in clinical cure and microbiological eradication in a global phase 3 trial.
Read More
Alabama Supreme Court ruling halts IVF treatment at UAB
February 22nd 2024Following a landmark decision regarding the status of embryos, the University of Alabama at Birmingham has suspended in vitro fertilization services, sparking concerns over reproductive rights and health care access as experts grapple with the legal aftermath.
Read More
Study reveals link between opioid dosage and spontaneous preterm birth risk
February 21st 2024Recent research highlighted an association between the total dose of prescribed opioids during pregnancy and the heightened risk of spontaneous preterm birth, emphasizing the need for judicious opioid use in pain management for expectant mothers.
Read More
Assessing Onclarity HPV assay safety and efficacy for cervical cancer screening
February 21st 2024A recent study evaluated the safety and effectiveness of the Onclarity HPV assay in detecting high-grade cervical disease, presenting findings on its comparability to predicate assays and potential for cost-saving benefits in screening practices.
Read More
Open vs minimally invasive hysterectomy outcomes with enhanced recovery after surgery
February 21st 2024Discover how immediate postoperative symptom burden varies between open and minimally invasive hysterectomies under enhanced recovery after surgery protocols, shedding light on recovery disparities in gynecologic surgery.
Read More
Gender disparity in physical activity and mortality risk
February 20th 2024A recent study revealed that physical activity confers greater reductions in all-cause and cardiovascular mortality risk among women compared to men, emphasizing the importance of closing the gender gap in exercise participation.
Read More
Study finds relugolix-CT Improves HMB in Black women
February 19th 2024Recent research highlights the efficacy and safety of relugolix combination therapy in managing uterine fibroid-associated heavy menstrual bleeding specifically among Black women, demonstrating outcomes comparable to the broader population.
Read More
CDC data reveals surge in maternal syphilis rates
February 16th 2024The Centers for Disease Control and Prevention's latest report unveils a 222% rise in maternal syphilis cases per 100,000 live births from 2016 to 2022, with increases observed across racial, age, and perinatal care groups nationwide.
Read More
Unifying radical hysterectomy classifications with the Querleu-Morrow
February 16th 2024Explore how the latest research underscores the efficacy of the 2017 Querleu-Morrow classification in defining radical hysterectomy extent, shedding light on surgical terminologies for cervical cancer management.
Read More
Cefepime–Taniborbactam outperforms meropenem in treating complicated UTI
February 15th 2024A recent study demonstrated the superior efficacy of cefepime–taniborbactam over meropenem for managing complicated urinary tract infections, suggesting a promising treatment option amid rising antibiotic resistance challenges.
Read More